Literature DB >> 28927159

Diagnostic value of inflammatory cell infiltrates, tumor stroma percentage and disease-free survival in patients with colorectal cancer.

Katarzyna Jakubowska1, Wojciech Kisielewski2, Luiza Kańczuga-Koda1, Mariusz Koda3, Waldemar Famulski1,2.   

Abstract

The anticancer immune defense mechanism involves humoral and cellular responses. The main effector mechanisms of antitumor responses involve the following: the activity of cytotoxic T cells; the activation of macrophages and neutrophils; the activity of cytokines secreted by T cells; and natural killer cell activity. Selected cell populations are responsible for the stimulation or suppression of the immune system against tumor cells. Therefore, the aim of the present study was to evaluate the location, extent and composition of the cellular inflammatory infiltration of tumors in patients with colorectal cancer (CRC). In addition, the correlation between cellular inflammatory infiltration, and anatomoclinical and histopathological features of patients was evaluated. The study involved 160 patients diagnosed with primary operable CRC. The local inflammatory infiltrate was assessed in the invasive front and center of the tumor using light microscopy with hematoxylin and eosin (H&E) staining, according to the Klintrup-Makinen criteria, tumor stroma percentage, and Glasgow microenvironment score. The inflammatory infiltrate in the invasive front of the tumor was correlated with gender (P=0.018), the invasion of blood vessels (P=0.020) and lymph vessels (P=0.038), the presence of tumor-infiltrating lymphocytes in the invasive front (P=0.033) and center (P<0.001) of the tumor, fibrosis (P<0.001), and the degree of desmoplasmic stroma (P=0.004). In contrast, inflammatory infiltration in the center of the tumor was associated with the tumor node metastasis stage (P=0.012), Dukes' stage (P=0.009), primary tumor stage (P=0.036), lymph node status (P=0.005), number of lymph nodes (P=0.006), invasion of lymph node pouches (P=0.021), size of lymph node metastasis (P=0.025) and the degree of desmoplasmic stroma (P=0.002). The low-group, who demonstrated an absent or weak inflammatory cell infiltrate in the invasive front of the tumor, had a statistically significant shorter disease-free survival (DFS) time (P=0.004). Inflammatory cell infiltrate in the invasive front was identified as an independent predictive factor in CRC (P=0.041). In conclusion, the degree of inflammatory cell infiltration in the invasive front of the primary tumor significantly affects various variables that determine disease progression and DFS rates of patients with CRC. Furthermore, the routine histopathological assessment of this parameter in tissue stained with H&E may have potential prognostic value.

Entities:  

Keywords:  TSP; colorectal cancer; immune response; inflammatory cell infiltration

Year:  2017        PMID: 28927159      PMCID: PMC5588066          DOI: 10.3892/ol.2017.6639

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  27 in total

1.  New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

Authors:  P Therasse; S G Arbuck; E A Eisenhauer; J Wanders; R S Kaplan; L Rubinstein; J Verweij; M Van Glabbeke; A T van Oosterom; M C Christian; S G Gwyther
Journal:  J Natl Cancer Inst       Date:  2000-02-02       Impact factor: 13.506

2.  Inflammation and prognosis in colorectal cancer.

Authors:  Kai Klintrup; Johanna M Mäkinen; Saila Kauppila; Päivi O Väre; Jukka Melkko; Hannu Tuominen; Karoliina Tuppurainen; Jyrki Mäkelä; Tuomo J Karttunen; Markus J Mäkinen
Journal:  Eur J Cancer       Date:  2005-10-18       Impact factor: 9.162

3.  Proliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity.

Authors:  O Nakano; M Sato; Y Naito; K Suzuki; S Orikasa; M Aizawa; Y Suzuki; I Shintaku; H Nagura; H Ohtani
Journal:  Cancer Res       Date:  2001-07-01       Impact factor: 12.701

4.  The relationship between tumour stroma percentage, the tumour microenvironment and survival in patients with primary operable colorectal cancer.

Authors:  J H Park; C H Richards; D C McMillan; P G Horgan; C S D Roxburgh
Journal:  Ann Oncol       Date:  2014-01-23       Impact factor: 32.976

5.  Reduced expression of microenvironmental Th1 cytokines accompanies adenomas-carcinomas sequence of colorectum.

Authors:  Guanglin Cui; Rasmus Goll; Trine Olsen; Sonja Eriksson Steigen; Anne Husebekk; Barthold Vonen; Jon Florholmen
Journal:  Cancer Immunol Immunother       Date:  2006-12-08       Impact factor: 6.968

6.  Role of desmoplasia in recurrence of stage II colorectal cancer within five years after surgery and therapeutic implication.

Authors:  Pietro Crispino; Giorgio De Toma; Antonio Ciardi; Antonino Bella; Margherita Rivera; Giuseppe Cavallaro; Andrea Polistena; Francesca Fornari; Hans Unim; Roberta Pica; Claudio Cassieri; Pietro Luigi Mingazzini; Paolo Paoluzi
Journal:  Cancer Invest       Date:  2008-05       Impact factor: 2.176

7.  Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer.

Authors:  Lin Zhang; Jose R Conejo-Garcia; Dionyssios Katsaros; Phyllis A Gimotty; Marco Massobrio; Giorgia Regnani; Antonis Makrigiannakis; Heidi Gray; Katia Schlienger; Michael N Liebman; Stephen C Rubin; George Coukos
Journal:  N Engl J Med       Date:  2003-01-16       Impact factor: 91.245

8.  The relationships between cellular components of the peritumoural inflammatory response, clinicopathological characteristics and survival in patients with primary operable colorectal cancer.

Authors:  C H Richards; K M Flegg; C S D Roxburgh; J J Going; Z Mohammed; P G Horgan; D C McMillan
Journal:  Br J Cancer       Date:  2012-05-17       Impact factor: 7.640

Review 9.  Tumour-infiltrating inflammation and prognosis in colorectal cancer: systematic review and meta-analysis.

Authors:  Z Mei; Y Liu; C Liu; A Cui; Z Liang; G Wang; H Peng; L Cui; C Li
Journal:  Br J Cancer       Date:  2014-02-06       Impact factor: 7.640

10.  The role of tumour stroma in colorectal cancer invasion and metastasis.

Authors:  John Conti; Gareth Thomas
Journal:  Cancers (Basel)       Date:  2011-04-26       Impact factor: 6.639

View more
  5 in total

1.  Molecular subtyping, tumor infiltration, and trimodal therapy for muscle-invasive bladder cancer: more questions than answers.

Authors:  Ronald Kool; José João Mansure; Wassim Kassouf
Journal:  Transl Androl Urol       Date:  2019-07

2.  Deciphering the immune microenvironment of a tissue by digital imaging and cognition network.

Authors:  A Lopès; Al H Cassé; E Billard; E Boulcourt-Sambou; G Roche; C Larois; N Barnich; S Naimi; M Bonnet; B Dumas
Journal:  Sci Rep       Date:  2018-11-12       Impact factor: 4.379

3.  Impact of Tumor-Stroma Ratio on the Prognosis of Colorectal Cancer: A Systematic Review.

Authors:  Jinlai Gao; Zhangguo Shen; Zaixing Deng; Lina Mei
Journal:  Front Oncol       Date:  2021-11-16       Impact factor: 6.244

4.  Neutrophil infiltration combined with necrosis in the primary tumor is a useful prognostic indicator for three-year disease-free survival time in patients with colorectal cancer.

Authors:  Katarzyna Jakubowska; Mariusz Koda; Małgorzata Grudzińska; Wojciech Kisielewski; Karolina Lomperta; Waldemar Famulski
Journal:  Oncol Lett       Date:  2022-05-06       Impact factor: 2.967

5.  Assessment of Histological Features in Squamous Cell Carcinoma Involving Head and Neck Skin and Mucosa.

Authors:  Ana Caruntu; Liliana Moraru; Mihai Lupu; Diana Alina Ciubotaru; Marius Dumitrescu; Lucian Eftimie; Radu Hertzog; Sabina Zurac; Constantin Caruntu; Oana Cristina Voinea
Journal:  J Clin Med       Date:  2021-05-27       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.